Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase

Outstanding results have been obtained in the treatment of chronic myeloid leukemia (CML) with first-line imatinib therapy. However, approximately 35% of patients will not obtain long-term benefit with this approach. Allogeneic hematopoietic stem cell transplantation (HCT) is a valuable second- and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Pavlů, Jiří, Kew, Andrea K., Taylor-Roberts, Beatrice, Auner, Holger W., Marin, David, Olavarria, Eduardo, Kanfer, Edward J., MacDonald, Donald H., Milojkovic, Dragana, Rahemtulla, Amin, Rezvani, Katayoun, Goldman, John M., Apperley, Jane F., Szydlo, Richard M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2010
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6143151/
https://ncbi.nlm.nih.gov/pubmed/20304808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-01-263624
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados